Trials / Conditions / Overactive Bladder

Overactive Bladder

494 registered clinical trials studyying Overactive Bladder — 51 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children NCT06769854	Chi Dang Hornik	Phase 4
Not Yet Recruiting	Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease NCT07187466	VA Office of Research and Development	Phase 4
Withdrawn	The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasi NCT05393921	University Hospitals Cleveland Medical Center	Phase 4
Recruiting	Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement NCT04527445	Loma Linda University	N/A
Not Yet Recruiting	The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency NCT07513363	Tarik Emre Sener	N/A
Recruiting	Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet NCT06201013	Children's Hospital of Chongqing Medical University	N/A
Not Yet Recruiting	Turkish USIQ: Validity & Reliability NCT07452796	Izmir Democracy University	—
Not Yet Recruiting	Mirabegron in Patients With Age-Related Macular Degeneration NCT07305298	University of Naples	—
Enrolling By Invitation	The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder NCT07463326	Inonu University	N/A
Not Yet Recruiting	Bladder Overactivity and Post-Botulinum Toxin Telemonitoring NCT07379372	University Hospital, Grenoble	N/A
Recruiting	Add-On ZIDA Sock Therapy for Overactive Bladder NCT07432659	Medical University of South Carolina	N/A
Not Yet Recruiting	Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women NCT07429734	Mansoura University	Phase 3
Not Yet Recruiting	A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections NCT07387315	TriHealth Inc.	Phase 4
Recruiting	Yoga for Treatment of Overactive Bladder in Pediatric Patients NCT05895045	Duke University	N/A
Not Yet Recruiting	Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly NCT07357714	Chinese PLA General Hospital	—
Recruiting	Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women NCT07209397	InMode MD Ltd.	N/A
Recruiting	Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation NCT06983470	University of Michigan	N/A
Recruiting	At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women NCT07178314	Oregon Health and Science University	N/A
Not Yet Recruiting	Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805	Hartford HealthCare	—
Not Yet Recruiting	NeuroGyn Genital Neuromodulation System for iOAB Treatment NCT06529198	Prof. Dr. med. Marc Possover	N/A
Withdrawn	Prophylactic Analgesia for Bladder Botox Injections NCT06514430	Montefiore Medical Center	Phase 4
Completed	Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females NCT07312955	Ain Shams University	N/A
Recruiting	Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients NCT06921746	University Hospital Ostrava	—
Recruiting	Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity NCT06935240	Selcuk University	N/A
Recruiting	Tensi+ European Registry NCT07205445	Stimuli Technology	—
Not Yet Recruiting	Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity NCT05910983	Menoufia University	N/A
Not Yet Recruiting	Diversity in Patients With OAB NCT05903105	University Hospital, Ghent	—
Completed	Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Tria NCT06489951	Xing Liu	N/A
Not Yet Recruiting	Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Inject NCT06695585	University of Louisville	Phase 4
Not Yet Recruiting	Effect of Pelvic Floor Down-training on Women With Idiopathic Overactive Bladder NCT06662565	Cairo University	N/A
Recruiting	Sacral Neuromodulation for Male Overactive Bladder (MOAB) NCT06511141	Axonics, Inc.	N/A
Completed	Usability Study of the FemPulse System NCT06347380	FemPulse Corporation	N/A
Enrolling By Invitation	Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study NCT06563193	Erzincan Binali Yildirim Universitesi	—
Recruiting	Sexual Dysfunction in Women With Multiple Sclerosis (MS) NCT07193823	Ege University	—
Not Yet Recruiting	Optimal Injection Interval for Intra-Detrusor Botulinum Toxin NCT06483217	Louisiana State University Health Sciences Center in New Orleans	N/A
Completed	Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder NCT06206512	Sarfez Pharmaceuticals, Inc.	Phase 2
Completed	Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women NCT06508944	Mahidol University	Phase 4
Enrolling By Invitation	Migraine Medication Effects on Urinary Symptoms NCT06212661	The Cleveland Clinic	—
Recruiting	Bladder Botox UTI Antibiotic Prophylaxis NCT06387329	Walter Reed National Military Medical Center	Phase 4
Unknown	A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin C NCT06181591	Seoul National University Hospital	Phase 2
Completed	Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder NCT06484023	Hopital Nord Franche-Comte	—
Recruiting	Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis NCT05772637	Assistance Publique - Hôpitaux de Paris	N/A
Withdrawn	Virtual Reality (VR) During Peripheral Nerve Evaluation (PNE) Procedure NCT05928910	University of Miami	N/A
Completed	rTMS in Overactive Bladder NCT06198439	The Methodist Hospital Research Institute	N/A
Recruiting	Percutaneous Nerve Evaluation Trial Time NCT06226220	University of Chicago	N/A
Active Not Recruiting	Deprescribing dRrugs for Overactive Bladder in General Practice (DROP) NCT06110975	Anne Estrup Olesen	N/A
Recruiting	Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS NCT06072703	The Methodist Hospital Research Institute	N/A
Completed	Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfu NCT06059066	The Methodist Hospital Research Institute	N/A
Recruiting	Comparison of a Paper and Automated Bladder Diary in Pediatric Patients NCT06070675	Universiteit Antwerpen	N/A
Active Not Recruiting	Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder NCT05977634	Ege University	N/A
Enrolling By Invitation	Evaluation of Efficacy and Patient Satisfaction of Local Anaesthesia Versus Sedoanalgesia for Botox (R) Inject NCT06437899	Hospital LKH Hochsteiermark - Leoben	N/A
Recruiting	Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease NCT05997043	Zhujiang Hospital	EARLY_Phase 1
Recruiting	Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms NCT05878951	Northwestern University	Phase 2 / Phase 3
Recruiting	Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder NCT05798403	Yin Ping	N/A
Completed	Transvaginal Radiofrequency Ablation for Overactive Bladder NCT06458556	InMode MD Ltd.	N/A
Completed	Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female NCT06345677	Vensica Therapeutics Ltd.	N/A
Recruiting	Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead NCT05799313	The Cleveland Clinic	N/A
Active Not Recruiting	Reduced-dose Botox for Urgency Incontinence Among Elder Females NCT05512039	Dartmouth-Hitchcock Medical Center	Phase 1 / Phase 2
Completed	Lidocaine Patches Prior to Percutaneous Nerve Evaluation NCT05783219	University of Louisville	Phase 2
Recruiting	Lower Urinary Tract Symptoms After Intravesical Therapy NCT05844059	Ludwig-Maximilians - University of Munich	—
Recruiting	Noninvasive Ultrasound Assessment of Detrusor Dysfunction NCT05652023	Mayo Clinic	—
Completed	Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive NCT06024005	Ege University	N/A
Terminated	Stress and Anxiety Effects on Overactive Bladder NCT05087810	Vanderbilt University Medical Center	—
Unknown	Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bl NCT05672277	Ankara Yildirim Beyazıt University	N/A
Unknown	Comparison of the Effects of External Electrical Stimulation Protocols in Women With Overactive Bladder NCT05672290	Ankara Yildirim Beyazıt University	N/A
Recruiting	A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE) NCT05685433	Valencia Technologies Corporation	N/A
Completed	Effects of Spinal Stabilization Exercises Focusing on the Pelvic Floor in Women With Overactive Bladder NCT05677841	Ankara Yildirim Beyazıt University	N/A
Completed	Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children NCT05709990	Xing Liu	N/A
Recruiting	Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bla NCT05997992	Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation	N/A
Terminated	PTNS for Female Patients Suffering From Multiple Sclerosis NCT05422625	Corewell Health East	N/A
Recruiting	Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks NCT05557279	Loyola University	Phase 4
Unknown	Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Sur NCT03280316	Xuanwu Hospital, Beijing	N/A
Completed	Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection NCT05719285	The Cleveland Clinic	Phase 4
Unknown	Developing a Simple Test to Diagnose Overactive Bladder NCT05572918	Teesside University	—
Completed	AURA-2: Augmenting Urinary Reflex Activity NCT05241379	Amber Therapeutics Ltd	N/A
Completed	Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke NCT05557175	The Hong Kong Polytechnic University	N/A
Unknown	Codesign of an Optical Device to Measure Urine Flow and Volume NCT05576311	Teesside University	—
Recruiting	TReating Incontinence for Underlying Mental and Physical Health NCT05362292	University of California, San Francisco	Phase 4
Completed	Management of OAB in Female Patients . NCT06184334	Elsayed Abdelhalim Elsayed	N/A
Unknown	The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder NCT05415865	Herlev and Gentofte Hospital	Phase 3
Active Not Recruiting	Treatment of Overactive Bladder With Anticholinergic Agents NCT07046156	Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital	—
Unknown	Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized C NCT05452434	Peking Union Medical College Hospital	Phase 4
Completed	Procedural Discomfort Related to Number of Intradetrusor Botox Injections NCT05652036	The Methodist Hospital Research Institute	Phase 4
Terminated	INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder NCT05309993	University of New Mexico	N/A
Completed	Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy NCT07337252	Mackay Memorial Hospital	—
Completed	Evaluation of the Tensi+ Device for the Treatment of Overactive Bladder NCT06847789	Stimuli Technology	—
Completed	A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder NCT05282069	Dong-A ST Co., Ltd.	Phase 3
Completed	Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial NCT05308979	University of California, Irvine	Phase 4
Terminated	A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable NCT05381116	Avation Medical, Inc.	N/A
Withdrawn	AURA 1: Augmenting Urinary Reflex Activity: Study 1 NCT05256498	Amber Therapeutics Ltd	N/A
Unknown	Acupuncture for Overactive Bladder in Adults NCT05158361	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	N/A
Completed	Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms NCT05162833	Theranova, L.L.C.	N/A
Unknown	Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children NCT05240456	Mansoura University	Phase 1 / Phase 2
Completed	Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2) NCT05226286	MedtronicNeuro	N/A
Recruiting	Pelvic Health Electrically Evoked Recording (PEER) 2 Study NCT05200923	MedtronicNeuro	N/A
Completed	Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB) NCT06569342	University of Aarhus	—
Unknown	Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bl NCT05157295	Augusta University	Phase 4
Completed	TEST-ON - Does iStim Reduce Urinary Urgency? NCT04957524	University of California, Los Angeles	N/A
Unknown	Sacral Neuromodulation in Neurogenic Patients NCT05688644	Omri Schwarztuch Gildor	—
Unknown	Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Pr NCT02279615	St. Joseph's Healthcare Hamilton	Phase 4
Unknown	Acupuncture Combined With Mirabegron in the Treatment of OAB NCT06181019	The Affiliated Ganzhou Hospital of Nanchang University	Phase 1
Recruiting	BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder NCT04873037	Corewell Health East	N/A
Unknown	Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB NCT05494567	Mansoura University	Phase 4
Completed	Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms NCT04758247	Theranova, L.L.C.	N/A
Unknown	Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence NCT05099419	University of Southern California	EARLY_Phase 1
Completed	Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) NCT05067478	Urovant Sciences GmbH	—
Completed	Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study) NCT04907032	University of Alabama at Birmingham	Phase 4
Unknown	Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence NCT04936464	Kaiser Permanente	N/A
Completed	Evaluating a Digital Intervention for Overactive Bladder NCT05170100	National University of Ireland, Galway, Ireland	N/A
Unknown	Treatment of Overactive Bladder With a Digital Conversational Agent: the MOTIVATION Study NCT04853849	Renalis	—
Completed	Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms NCT04999657	Medtecx Co Ltd.	N/A
Completed	Effects of Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Adults NCT05464589	Dow University of Health Sciences	N/A
Unknown	The Effects of Pelvic Floor Muscle Training in Women With Overactive Bladdder NCT04950556	Ataturk Training and Research Hospital	N/A
Completed	Overactive Bladder Telemedicine Non-inferiority Trial NCT05117918	University of California, Los Angeles	N/A
Terminated	OAB and the Microbiome NCT04831801	University of Miami	—
Completed	Strong Desire to Void and Balance in Older Women With Overactive Bladder NCT04910555	Assistance Publique - Hôpitaux de Paris	—
Completed	Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study NCT04873271	MedtronicNeuro	N/A
Unknown	Impact of OAB Symptoms on Quality of Life in Croatia NCT04865328	University of Zagreb	—
Recruiting	Antibiotic Usage Prior to OnabotulinumtoxinA Injection NCT04754737	Benaroya Research Institute	N/A
Completed	Intravaginal Electrical Stimulation With Different Treatment Frequency in Women With Idiopathic Overactive Bla NCT04734301	Pamukkale University	N/A
Completed	Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overacti NCT04681625	Comenius University	N/A
Completed	FREEOAB Study for Overactive Bladder NCT04547920	Avation Medical, Inc.	N/A
Completed	The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections NCT04479709	MetroHealth Medical Center	—
Completed	Nerve Stimulation Using a TENS to Provide Pain Relief During Surgery for Overactive Bladder NCT05330117	University of Rochester	N/A
Terminated	TENS Used for Pain Management During Office Cystoscopy Botox Injections NCT04448171	Mayo Clinic	N/A
Completed	Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder ( NCT04545580	Bayer	Phase 2
Completed	Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence NCT04470765	Exodus Innovations	N/A
Unknown	"The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity" NCT04578899	Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation	N/A
Terminated	InterStim Micro Post Market Clinical Follow-up Study (ELITE) NCT04506866	MedtronicNeuro	N/A
Completed	BE Technologies Mobile Uroflowmetry Validation Study NCT04599283	BE Technologies Inc	N/A
Completed	Minimizing Pain During Office Intradetrussor Botox Injection NCT04270526	Boston Urogynecology Associates	Phase 4
Completed	Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid o NCT04471337	Bayer	Phase 1
Completed	A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Par NCT04487431	Bayer	Phase 1
Completed	Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid NCT04454424	Bayer	Phase 1
Completed	A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers. NCT04485585	Boryung Pharmaceutical Co., Ltd	Phase 1
Completed	Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO NCT04437108	Mansoura University	N/A
Completed	Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by NCT04423744	Bayer	Phase 1
Unknown	What is the Effect of Prolapse Surgery on Voiding? NCT04429360	Universiteit Antwerpen	—
Completed	Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Synd NCT05250245	Yuzuncu Yil University	Phase 4
Completed	To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder NCT04917315	Jeil Pharmaceutical Co., Ltd.	Phase 3
Completed	Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder NCT04186442	Hugel	Phase 1
Unknown	NOGO for an Overactive Bladder NCT04357223	SagaNatura	Phase 2
Unknown	Effects of Low-intensity Excoporeal Shock Wave Therapy (LiESWT) on Women With Pelvic Floor Dysfunction NCT05337813	Kaohsiung Medical University Chung-Ho Memorial Hospital	N/A
Withdrawn	Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive Bladder NCT03753750	University of Southern California	N/A
Unknown	Effectiveness of EMS and TENS in Patients With Overactive Bladder NCT04364438	Isra University	N/A
Completed	Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug NCT04265781	Bayer	Phase 1
Completed	High Intensity Focused Electromagnetic Field Device for Urinary Incontinence NCT04031014	Boston Urogynecology Associates	N/A
Completed	AQUA: Anticholinergic Side Effects QUestionnAire NCT04791111	Pierre and Marie Curie University	—
Completed	Comparison of Different Treatments for Overactive Bladder Syndrome NCT04197466	Ankara Yildirim Beyazıt University	N/A
Completed	InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study NCT04016324	MedtronicNeuro	N/A
Completed	Is 10 Injections of Bladder Botox Less Painful Than 20 Injections? NCT04124939	Wake Forest University Health Sciences	Phase 4
Completed	In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder NCT04155593	TriHealth Inc.	—
Completed	Effectiveness of Microcurrents Therapy in Overactive Bladder. NCT04120545	University of Las Palmas de Gran Canaria	N/A
Completed	Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder NCT06123364	Serdinsek Tamara	N/A
Completed	Clinical Feasibility Study, Implantable Tibial Nerve Stimulator (ITNS) NCT04115228	Nine Continents Medical, Inc.	N/A
Completed	Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benig NCT04103450	Urovant Sciences GmbH	Phase 3
Unknown	Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder NCT04113941	Medy-Tox	Phase 3
Completed	Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladde NCT03817931	Baylor Research Institute	Phase 4
Completed	Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder NCT05013593	Regionshospital Nordjylland	N/A
Recruiting	Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Blad NCT04020510	Walter Reed National Military Medical Center	Phase 4
Completed	Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder NCT05463822	Stanford University	EARLY_Phase 1
Terminated	Pelvic Floor Muscle Training With Leva System for Urge Incontinence NCT03923348	The Christ Hospital	N/A
Completed	ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients NCT04626960	Pamukkale University	—
Completed	Optimizing Overactive Bladder Treatment NCT03904407	University of North Carolina, Chapel Hill	N/A
Unknown	The Treatment Efficacy of Prolotherapy in Bladder Voiding Dysfunction NCT05485142	Taichung Armed Forces General Hospital	N/A
Completed	Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Po NCT04570605	University of Utah	N/A
Completed	Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Sympt NCT03902080	Urovant Sciences GmbH	Phase 3
Completed	eCoin for OAB Feasibility Follow-on Study NCT03655054	Valencia Technologies Corporation	N/A
Completed	PTNS on Urinary and Global Quality of Life in MS Patients NCT04063852	University of Michigan	—
Completed	Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSS NCT04309890	Mutah University	—
Completed	Impact of Decision Aids in Urogynecology NCT04369404	Massachusetts General Hospital	N/A
Completed	Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in NCT03874780	Vensica Therapeutics Ltd.	N/A
Unknown	The Clinical Effects of Laser Acupuncture Therapy for OAB Women. NCT03829137	Chang Gung Memorial Hospital	N/A
Terminated	Group Medical Visits for Latina Women With Urgency Urinary Incontinence NCT03687164	University of Southern California	N/A
Completed	Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home NCT03595215	Theranova, L.L.C.	N/A
Completed	Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence NCT03556891	Valencia Technologies Corporation	N/A
Unknown	TPTNS: Home vs Hospital Treatment for Overactive Bladder NCT03727711	NHS Greater Glasgow and Clyde	N/A
Completed	Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder NCT06250543	Niko Kavcic	Phase 4
Terminated	OnabotulinumtoxinA Bladder Injection Study NCT03523091	Corewell Health East	Phase 4
Completed	Fluids Affecting Bladder Urgency and Lower Urinary Symptoms NCT03625492	University of Michigan	N/A
Unknown	Experience Sampling Method in OAB Patients NCT03435991	Maastricht University Medical Center	—
Withdrawn	Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use NCT02522936	University of Southern California	Phase 4
Completed	A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder NCT03566134	Dong-A ST Co., Ltd.	Phase 2
Completed	A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women NCT03594058	Velicept Therapeutics, Inc.	Phase 2
Terminated	Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection NCT03508921	Vanderbilt University Medical Center	Phase 4
Completed	An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactiv NCT03583372	Urovant Sciences GmbH	Phase 3
Unknown	Effects of Connective Tissue Massage in Women With Overactive Bladder NCT03695692	Seyda TOPRAK CELENAY	N/A
Completed	A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) NCT03492281	Urovant Sciences GmbH	Phase 3
Completed	Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation NCT03547518	Corewell Health East	N/A
Unknown	Efficacy and Safety of Electroacupuncture and Acupuncture in Postmenopausal Women With Overactive Bladder NCT03260907	DongGuk University	N/A
Completed	Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease NCT03149809	VA Office of Research and Development	Phase 3
Unknown	The Effect of Low Intensity Extracorporeal Low Energy Shock Wave Therapy on Stress Urinary Incontinence and Ov NCT04059133	Kaohsiung Medical University Chung-Ho Memorial Hospital	N/A
Completed	Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women NCT03475706	Velicept Therapeutics, Inc.	Phase 2
Completed	Information, Motivation, Behavioral Skills Model on Urinary Incontinence and Quality of Life in Men NCT04068025	Ankara Yildirim Beyazıt University	N/A
Unknown	Assessment of Potential Biomarkers in Women With Symptoms of Overactive Bladder and Pelvic Organ Prolapse NCT03516292	Aristotle University Of Thessaloniki	—
Unknown	Comparison of Two Forms of Transcutaneous Electrical Stimulation in Overactive Bladder NCT03742206	Hospital de Clinicas de Porto Alegre	N/A
Completed	Lidocaine for Pain After Urodynamic Testing NCT03390790	Atlantic Health System	Phase 4
Unknown	The Efficacy of Botulinum Toxin in OVERACTIVE Bladder NCT03888001	Assiut University	—
Completed	Tactile Imaging and Electromyography NCT03477214	Advanced Tactile Imaging, Inc.	—
Completed	Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder NCT03371342	Medy-Tox	Phase 1
Unknown	Standardization of Lead Placement for Sacral Neuromodulation Part 2 NCT03199443	Universiteit Antwerpen	—
Completed	Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. NCT03175029	Taiho Pharmaceutical Co., Ltd.	Phase 2
Unknown	Standardization of Lead Placement for Sacral Neuromodulation. Part 1 NCT03194425	Universiteit Antwerpen	N/A
Completed	Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence NCT03643380	Neuspera Medical, Inc.	Phase 1
Unknown	Sacral Neuromodulation & Urodynamics NCT03614767	Universiteit Antwerpen	—
Completed	Mirabegron For Erectile Dysfunction NCT02916693	Johns Hopkins University	Phase 1 / Phase 2
Unknown	Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease NCT03412513	Seoul National University Hospital	Phase 4
Completed	Reproductibility of Cystometry in Multiple Sclerosis Patient NCT03451175	Pierre and Marie Curie University	—
Terminated	Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections NCT03080389	The Cleveland Clinic	—
Withdrawn	Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder NCT03087578	University Hospitals Cleveland Medical Center	N/A
Completed	Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women NCT04619238	Medical University of Lublin	—
Completed	Reliability of Polish-Version Overactive Bladder Syndrom Scores (OABSS) NCT03801239	Medical University of Lublin	—
Completed	Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study NCT03057158	Duke University	—
Unknown	Comparison of Craniosacral Therapy vs Pelvic Floor Physical Therapy NCT03213522	CentraState Medical Center	N/A
Completed	Study of ONO-8577 in Patients With Overactive Bladder NCT03106623	Ono Pharmaceutical Co., Ltd.	Phase 2
Withdrawn	Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1 NCT03019094	BlueWind Medical	N/A
Completed	A Pilot Study Evaluating the Usability of the Oabi Mobile Application NCT04534946	Massachusetts General Hospital	—
Unknown	Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy NCT03061760	Collegium Medicum w Bydgoszczy	—
Unknown	Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial NCT02873312	Bioness Inc	N/A
Completed	Sexual Function Trial of Overactive Bladder: Medication Versus PTNS NCT03500146	Medstar Health Research Institute	—
Unknown	Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A NCT03385460	Mansoura University	N/A
Completed	TTNS vs PTNS in a County Hospital System. NCT07353944	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	N/A
Completed	Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder NCT03558919	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	Phase 4
Unknown	Low-level Light Therapy for Overactive Bladder and Urinary Incontinence NCT02980328	Seoul National University Hospital	Phase 3
Terminated	Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactiv NCT02995967	University of Alabama at Birmingham	N/A
Completed	Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested Need NCT03136601	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	N/A
Withdrawn	Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulat NCT02674269	UroGen Pharma Ltd.	Phase 1 / Phase 2
Completed	Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing NCT03625843	San Antonio Uniformed Services Health Education Consortium	N/A
Completed	PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patie NCT02857816	MedtronicNeuro	N/A
Completed	Investigation of the Effect of the Female Urinary Microbiome on Incontinence NCT02835846	Loyola University	Phase 4
Completed	A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment NCT02240459	University of Alberta	Phase 2
Withdrawn	A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone NCT02297178	Medway NHS Foundation Trust	—
Completed	Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment NCT03575702	R-Pharm	Phase 3
Terminated	Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due NCT02660359	Ipsen	Phase 3
Terminated	A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder NCT02922842	University of Rochester	N/A
Terminated	Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer NCT02805452	Center Eugene Marquis	Phase 3
Completed	Efficacy of Biofeedback PFMT and Medication in Women With Overactive Bladder NCT04477265	Far Eastern Memorial Hospital	N/A
Completed	A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking NCT02757768	Astellas Pharma Global Development, Inc.	Phase 4
Unknown	A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects NCT02821312	Dong-A ST Co., Ltd.	Phase 1
Completed	Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) NCT02620410	Axonics, Inc.	N/A
Unknown	Urinary Biomarkers in Overactive Bladder in Children NCT02704013	Children's Hospital Zagreb	N/A
Completed	Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB NCT03017170	Weill Medical College of Cornell University	Phase 1
Completed	Percutaneous Nerve Evaluation With Fluoroscopy Versus Without NCT02677753	University of Louisville	N/A
Terminated	Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due NCT02660138	Ipsen	Phase 3
Unknown	Urinary Neurotrophin Levels in Healthy Children NCT02389270	Children's Hospital Zagreb	—
Completed	Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunte NCT02940314	Hanmi Pharmaceutical Company Limited	Phase 1
Withdrawn	Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms NCT02110680	Meir Medical Center	Phase 2
Completed	Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB) NCT02735499	The Hospital of Vestfold	Phase 2
Terminated	Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms NCT02865395	Campbell Grant	Phase 4
Unknown	A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB NCT02786407	Lanzhou Institute of Biological Products Co., Ltd	Phase 3
Completed	A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overact NCT02656173	Astellas Pharma Inc	Phase 4
Completed	A Trial of Transcutaneous Nerve Stimulation for OAB NCT02511717	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	N/A
Completed	A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric S NCT02526979	Astellas Pharma Europe B.V.	Phase 1
Completed	A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Ne NCT02590250	Allergan	—
Completed	Mirabegron in Parkinson Disease and Impaired Cognition NCT02536976	HealthPartners Institute	Phase 4
Completed	The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides NCT02524769	Loyola University	N/A
Completed	Reduction of Bladder Injection Pain With Belladonna Opiate Suppository NCT02600715	Edgar LeClaire, MD	Phase 4
Completed	Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB NCT02657057	Instituto Médico Tecnológico SL	N/A
Completed	A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic NCT02601287	Allergan	Phase 4
Completed	Overactive Bladder (OAB) Voiding Diary and Urodynamics Correlation Study NCT03473782	NYU Langone Health	—
Completed	Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. NCT02614482	Stéphane Bolduc	Phase 3
Completed	Acupuncture on Post-Stroke Overactive Bladder NCT02568774	The University of Hong Kong	N/A
Completed	The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. NCT02494349	Jeil Pharmaceutical Co., Ltd.	Phase 1
Completed	Fall Prevention in Older Adults With OAB NCT03946124	University of Pennsylvania	Phase 4
Completed	Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers NCT02447367	Jeil Pharmaceutical Co., Ltd.	Phase 1
Completed	Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility? NCT02540798	Sandwell & West Birmingham Hospitals NHS Trust	—
Completed	Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients W NCT02468375	Samsung Medical Center	Phase 4
Completed	The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse R NCT02502838	Icahn School of Medicine at Mount Sinai	—
Completed	Urinary Markers of Detrusor Overactivity in Spina Bifida Patients NCT02852317	Rennes University Hospital	—
Unknown	MIrabegron With oveRACtive bLadder Symptoms in mEn NCT02361502	Seoul National University Hospital	Phase 4
Terminated	Cystoscopic Ablation Via RF Energy Clinical Trial NCT02398578	Amphora Medical, Inc.	Phase 1 / Phase 2
Completed	Mirabegron and Urinary Urgency Incontinence NCT02495389	Loyola University	Phase 4
Completed	A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment NCT02386072	Astellas Scientific & Medical Affairs, Inc.	—
Completed	Training and Counseling Program for Overactive Bladder Treatment NCT03544554	Biruni University	N/A
Withdrawn	Neuromodulation Implantation Settings Variation for Overactive Bladder NCT02112786	Loma Linda University	N/A
Completed	Behavioural Therapy With Checklist for Overactive Bladder NCT03662893	Ankara Training and Research Hospital	N/A
Completed	Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB NCT02485067	SK Chemicals Co., Ltd.	Phase 3
Unknown	Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder NCT02335853	Bakirkoy Dr. Sadi Konuk Research and Training Hospital	—
Unknown	The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder NCT02315950	Cedars-Sinai Medical Center	N/A
Completed	Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children NCT02327936	Stéphane Bolduc	Phase 3
Completed	A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Rou NCT02320773	Astellas Pharma Europe Ltd.	—
Completed	Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in Females NCT03104101	Alexandria University	N/A
Unknown	Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study NCT02452879	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	N/A
Completed	The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients NCT02271607	Korean Medicine Hospital of Pusan National University	N/A
Completed	A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorpti NCT02211846	Astellas Pharma Inc	Phase 1
Withdrawn	Foot Neuromodulation for Overactive Bladder in Children NCT02320201	Rajeev Chaudhry	N/A
Completed	Controlling Urgency Through Relaxation Exercises NCT02202031	University of California, San Francisco	N/A
Completed	Audiovisual Stimulus During Urodynamics NCT02670486	Women and Infants Hospital of Rhode Island	N/A
Completed	Does Bladder Training Improve the Efficacy of Nerve Stimulation in Women With Refractory Overactive Bladders NCT02107820	University Hospital Plymouth NHS Trust	N/A
Completed	Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions NCT02197533	Unity Health Toronto	N/A
Completed	"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women" NCT02180048	Loma Linda University	N/A
Completed	Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin NCT02180997	Jeil Pharmaceutical Co., Ltd.	Phase 1
Unknown	Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation NCT02583529	Tatiane Gomes de Araujo	EARLY_Phase 1
Terminated	Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients NCT02179099	UroGen Pharma Ltd.	Phase 1 / Phase 2
Terminated	Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder NCT02129816	University of Zurich	Phase 2 / Phase 3
Completed	Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women NCT02143570	Universidad de Valparaiso	Phase 3
Completed	A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and NCT02045862	Astellas Pharma Europe B.V.	Phase 3
Terminated	Foot/Hand Neuromodulation for Overactive Bladder (OAB) NCT01972061	Christopher J Chermansky, MD	N/A
Completed	Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement. NCT02377765	Liverpool Women's NHS Foundation Trust	N/A
Terminated	Oxybutynin and Omega-3 for OAB (Overactive Bladder) NCT02070042	TriHealth Inc.	N/A

Showing the 300 most recent trials. Use search for older records.